Valuation Amgen Inc. Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 21/08/2026			5-day change	1st Jan Change
3.500 ^THB	-3.85%		+0.57%	-

08-21	FTC Challenges Amgen's Patent Play in Enbrel Antitrust Case	DJ
08-20	Piper Sandler Adjusts Price Target on Amgen to $457 From $427, Maintains Overweight Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	126,718	140,139	154,142	140,103	176,250	237,516	-	-
Change	-	10.59%	9.99%	-9.11%	25.8%	34.76%	-	-
Enterprise Value (EV) ¹	151,990	169,779	207,811	188,229	221,725	279,002	273,344	268,347
Change	-	11.7%	22.4%	-9.42%	17.8%	25.83%	-2.03%	-1.83%
P/E	21.9x	21.7x	23.1x	34.5x	23x	27.8x	24.9x	24x
PBR	18.7x	38.3x	24.7x	23.8x	20.4x	21x	17.1x	13.8x
PEG	-	1.2x	7.36x	-0.9x	0.3x	2.5x	2.1x	6.48x
Capitalization / Revenue	4.88x	5.32x	5.47x	4.19x	4.8x	6.1x	5.91x	5.72x
EV / Revenue	5.85x	6.45x	7.37x	5.63x	6.03x	7.17x	6.8x	6.46x
EV / EBITDA	9.61x	10.5x	11.9x	9.13x	10.4x	12.7x	12.3x	12.1x
EV / EBIT	12.2x	13.3x	15.5x	12.5x	13.7x	16.4x	15.5x	14.6x
EV / FCF	18.1x	19.3x	28.2x	18.1x	27.4x	25.1x	18.5x	17.4x
FCF Yield	5.51%	5.17%	3.54%	5.52%	3.65%	3.98%	5.39%	5.73%
Dividend per Share ²	7.04	7.76	8.52	9	9.52	10.09	10.66	11.12
Rate of return	3.13%	2.95%	2.96%	3.45%	2.91%	2.3%	2.43%	2.53%
EPS ²	10.28	12.11	12.49	7.56	14.23	15.81	17.68	18.33
Distribution rate	68.5%	64.1%	68.2%	119%	66.9%	63.8%	60.3%	60.7%
Net sales ¹	25,979	26,323	28,190	33,424	36,751	38,939	40,196	41,525
EBITDA ¹	15,822	16,178	17,470	20,620	21,370	21,919	22,189	22,265
EBIT ¹	12,424	12,761	13,399	15,028	16,203	16,964	17,660	18,321
Net income ¹	5,893	6,552	6,717	4,090	7,711	8,598	9,394	9,890
Net Debt ¹	25,272	29,640	53,669	48,126	45,475	41,486	35,828	30,831
Reference price ²	224.97	262.64	288.02	260.64	327.31	439.33	439.33	439.33
Nbr of stocks (in thousands)	563,266	533,579	535,178	537,533	538,481	540,632	-	-
Announcement Date	07/02/22	31/01/23	06/02/24	04/02/25	03/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.74x	12.95x	26.26x	0.55%	1,119B
JOHNSON & JOHNSON	30.06x	-	-	1.99%	651B
ABBVIE INC.	33.82x	7.82x	16.26x	2.59%	468B
ROCHE HOLDING AG	20.93x	4.96x	12.28x	2.66%	374B
NOVARTIS AG	22.59x	5.81x	14.4x	2.75%	302B
ASTRAZENECA PLC	21.37x	4.4x	12.49x	1.99%	259B
AMGEN INC.	27.79x	7.17x	12.73x	2.3%	238B
NOVO NORDISK A/S	13.71x	4.87x	10.23x	3.75%	208B
GILEAD SCIENCES, INC.	-44.65x	6.45x	25.18x	2.26%	181B
Average	17.93x	6.80x	16.23x	2.31%	422.21B
Weighted average by Cap.	25.51x	8.51x	18.70x	1.89%